These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18802104)

  • 21. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
    Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
    J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
    Tran EH; Prince EN; Owens T
    J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of PAF receptor alters cellular infiltrate but not rolling and adhesion of leukocytes in experimental autoimmune encephalomyelitis.
    Rodrigues DH; Lacerda-Queiroz N; de Miranda AS; Fagundes CT; Campos RD; Arantes RE; Vilela Mde C; Rachid MA; Teixeira MM; Teixeira AL
    Brain Res; 2011 Apr; 1385():298-306. PubMed ID: 21338585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
    Juedes AE; Ruddle NH
    J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF.
    Flamand N; Lefebvre J; Lapointe G; Picard S; Lemieux L; Bourgoin SG; Borgeat P
    J Leukoc Biol; 2006 May; 79(5):1043-51. PubMed ID: 16501051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
    Oliver AR; Lyon GM; Ruddle NH
    J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.
    Mills JH; Kim DG; Krenz A; Chen JF; Bynoe MS
    J Immunol; 2012 Jun; 188(11):5713-22. PubMed ID: 22529293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system.
    Du C; Sriram S
    J Immunol; 2002 Mar; 168(6):3105-12. PubMed ID: 11884485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders.
    Stahnke T; Stadelmann C; Netzler A; Brück W; Richter-Landsberg C
    J Mol Neurosci; 2007; 32(1):25-37. PubMed ID: 17873285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
    Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
    J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
    Garay LI; González Deniselle MC; Brocca ME; Lima A; Roig P; De Nicola AF
    Neuroscience; 2012 Dec; 226():40-50. PubMed ID: 23000619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.
    Marusic S; Thakker P; Pelker JW; Stedman NL; Lee KL; McKew JC; Han L; Xu X; Wolf SF; Borey AJ; Cui J; Shen MW; Donahue F; Hassan-Zahraee M; Leach MW; Shimizu T; Clark JD
    J Neuroimmunol; 2008 Nov; 204(1-2):29-37. PubMed ID: 18829119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.
    Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S
    J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urothelial cell platelet-activating factor production mediated by calcium-independent phospholipase A2γ.
    Rastogi P; Rickard A; Klumpp DJ; McHowat J
    Urology; 2011 Jan; 77(1):248.e1-7. PubMed ID: 21094990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
    Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
    Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis.
    Tokuhara N; Namiki K; Uesugi M; Miyamoto C; Ohgoh M; Ido K; Yoshinaga T; Yamauchi T; Kuromitsu J; Kimura S; Miyamoto N; Kasuya Y
    J Biol Chem; 2010 Oct; 285(43):33294-33306. PubMed ID: 20720005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
    Tsutsui S; Schnermann J; Noorbakhsh F; Henry S; Yong VW; Winston BW; Warren K; Power C
    J Neurosci; 2004 Feb; 24(6):1521-9. PubMed ID: 14960625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of phospholipase D1 in the spinal cords of rats with experimental autoimmune encephalomyelitis.
    Ahn M; Min DS; Kang J; Jung K; Shin T
    Neurosci Lett; 2001 Dec; 316(2):95-8. PubMed ID: 11742724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.